Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Soleno Therapeutics Inc shares valued at $316,971 were sold by Hirano Patricia C on Jul 01 ’25. At $82.76 per share, Hirano Patricia C sold 3,830 shares. The insider’s holdings dropped to 13,206 shares worth approximately $1.12 million following the completion of this transaction.
Also, PATRICIA HIRANO purchased 3,830 shares, netting a total of over 316,971 in proceeds.
Before that, Hirano Patricia C had sold 266 shares from its account. In a trade valued at $22,410, the insider traded Soleno Therapeutics Inc shares for $84.25 each. Upon closing the transaction, the insider’s holdings decreased to 266 shares, worth approximately $1.45 million.
As published in their initiating research note from TD Cowen on June 23, 2025, Soleno Therapeutics Inc [SLNO] has been a Buy and the price target has been revised to $110. As of December 02, 2024, Stifel has reiterated its “Buy” rating for SLNO. Earlier on December 02, 2024, Robert W. Baird resumed its rating. Their recommendation was “an Outperform” for SLNO stock.
Analyzing SLNO Stock Performance
On last trading session,, Soleno Therapeutics Inc [NASDAQ: SLNO] rose 1.07% to $84.86. The stock’s lowest price that day was $83.9205, but it reached a high of $86.88 in the same session. During the last five days, there has been a drop of approximately -2.96%. Over the course of the year, Soleno Therapeutics Inc shares have jumped approximately 75.05%.
Support And Resistance Levels for Soleno Therapeutics Inc (SLNO)
RSI (Relative Strength Index) is 51.86 on the 14-day chart, showing neutral technical sentiment.
Is Soleno Therapeutics Inc subject to short interest?
Stocks of Soleno Therapeutics Inc saw a sharp rise in short interest on 2025-07-15 jumping by 1.8 million shares to 5.87 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 4.06 million shares. A jump of 30.72% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.74 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.74.
Which companies own the most shares of Soleno Therapeutics Inc (SLNO)?
In terms of Soleno Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 105 in the next 12 months, up nearly 25.04% from the previous closing price of $83.97. Analysts anticipate Soleno Therapeutics Inc stock to reach 121 by 2025, with the lowest price target being 81. In spite of this, 3 analysts ranked Soleno Therapeutics Inc stock as Buy at the end of 2025. On September 03, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $70.
